Yes but its growth rates with respect to expenditures, and in particular capital expenditures (R&D etc), which we have no idea about.
Gross margins here are irrelevant: if they can't charge a high enough price to cover all expenditures and rely on cash raised via fund-raises, they are not financially healthy.
Could they be one day? Maybe.